Page last updated: 2024-10-15

conocurvone

Description

conocurvone: a trimeric naphthoquinone derivative; extracted from Conospermum incurvum; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
Conospermumgenus[no description available]ProteaceaeA plant family of the order Proteales, subclass Rosidae class Magnoliopsida. Cluster roots, bottlebrush-like clusters of rootlets which form in response to poor soil, are common in this family.[MeSH]

Cross-References

ID SourceID
PubMed CID135412596
CHEMBL ID509065
CHEBI ID3861
MeSH IDM0242886

Synonyms (17)

Synonym
conocurvone
149572-31-6
[8,8':9',8''-ter-3h-naphtho[2,1-b]pyran]-7,7',7'',10,10',10''-hexone, 9,9''-dihydroxy-3,3',3''-trimethyl-3,3',3''-tris(4-methyl-3-pentenyl)-, (3r,3'r,3''r)-
conocurvon
NSC650891 ,
(3r)-8,9-bis[(3r)-9-hydroxy-3-methyl-3-(4-methylpent-3-enyl)-7,10-dioxo-benzo[f]chromen-8-yl]-3-methyl-3-(4-methylpent-3-enyl)benzo[f]chromene-7,10-dione
nsc-650891
CHEMBL509065
chebi:3861 ,
nsc 650891
(8,8':9',8''-ter-3h-naphtho(2,1-b)pyran)-7,7',7'',10,10',10''-hexone, 9,9''-dihydroxy-3,3',3''-trimethyl-3,3',3''-tris(4-methyl-3-pentenyl)-, (3r,3'r,3''r)-
(+)-conocurvone
Q27106216
SCX7A45WJ6
[8,8':9',8''-ter-3h-naphtho[2,1-b]pyran]-7,7',7'',10,10',10''-hexone, 9,9''-dihydroxy-3,3',3''-trimethyl-3,3',3''-tris(4-methyl-3-penten-1-yl)-, (3r,3'r,3''r)-
(3r,3'r,3''r)-9,9''-dihydroxy-3,3',3''-trimethyl-3,3',3''-tris(4-methyl-3-penten-1-yl)[8,8':9',8''-ter-3h-naphtho[2,1-b]pyran]-7,7',7'',10,10',10''-hexone
DTXSID201100021
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organic heterotricyclic compoundAn organic tricyclic compound in which at least one of the rings of the tricyclic skeleton contains one or more heteroatoms.
organooxygen compoundAn organochalcogen compound containing at least one carbon-oxygen bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID580184Cytotoxicity against human HepG2(2.2.15) cells by neutral red dye uptake assay2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV).
AID397755Antiviral activity against HIV1 in human CEM-SS cells assessed as inhibition of virus-induced cytopathic effect2001Journal of natural products, Feb, Volume: 64, Issue:2
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
AID580183Antiviral activity against Hepatitis B virus infected in human HepG2(2.2.15) cells assessed as reduction in viral DNA by Southern blotting2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
Antiviral agents 3. Discovery of a novel small molecule non-nucleoside inhibitor of hepatitis B virus (HBV).
AID397756Therapeutic index, ratio of cytotoxicity against human CEM-SS cells to EC50 for HIV12001Journal of natural products, Feb, Volume: 64, Issue:2
Natural product-based anti-HIV drug discovery and development facilitated by the NCI developmental therapeutics program.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]